){kind=logo}
)
Patient Access in the US and Abroad
Patients' experiences differ between the US and Europe when it comes to having access to innovative medicines. This session will explore the potential implications of adopting HTA-like controls on US patient access.
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)